CDK9 and B-cell chronic lymphocytic leukemia: Flavopiridol acts by competing with ATP at the ATP-binding site of CDK9 and has been shown to decrease global levels of transcription in Drosophila,23 in HeLa or 293 cells24 and in chronic lymphocytic leukemia cells.23